Inventor · disambiguated record
Teit E. Johansen
Also filed as: JOHANSEN TEIT · JOHANSEN TEIT E
16 granted patents·11 pending applications·178 citations·filing 1999–2017
93Inventor score
Top patents by PatentIndex Score
27 records- 0194US7655463B2Methods of activating RET receptor tyrosine kinase using neurotrophic factorsBIOGEN IDEC INC·Filed 2008·Granted Feb 2, 2010·24 cites·16 claims
- 0294US7358228B2Methods of treating pain using neurotrophic factorsBIOGEN IDEC INC·Filed 2006·Granted Apr 15, 2008·23 cites·29 claims
- 0391US6734284B1Neublastin neurotrophic factorsNSGENE AS·Filed 2000·Granted May 11, 2004·42 cites·9 claims
- 0489US7276580B2Neurotrophic factorsNSGENE AS·Filed 2003·Granted Oct 2, 2007·24 cites·14 claims
- 0583US8334264B2Therapeutic use of a growth factor, METRNLJOERGENSEN JESPER ROLAND·Filed 2009·Granted Dec 18, 2012·8 cites·5 claims
- 0683US6593133B1Neurotrophic factorsNSGENE AS·Filed 1999·Granted Jul 15, 2003·43 cites·22 claims
- 0781US8404642B2Treatment of allodynia, hyperalgesia, spontaneous pain and phantom painJOERGENSEN JESPER ROLAND·Filed 2011·Granted Mar 26, 2013·6 cites·39 claims
- 0881US8217146B2Neurotrophic factors and methods of use thereofSAH DINAH W Y·Filed 2009·Granted Jul 10, 2012·4 cites·33 claims
- 0977US9068015B2Therapeutic use of a growth factor, METRNLNSGENE AS·Filed 2012·Granted Jun 30, 2015·3 cites·4 claims
- 1070US8815810B2Treatment of allodynia, hyperalgesia, spontaneous pain and phantom painNSGENE AS·Filed 2013·Granted Aug 26, 2014·1 cites·21 claims
- 1167US2010234293A1Novel Neurotrophic FactorsNSGENE AS·Filed 2009·Application pending·0 cites
- 1262US9314502B2Treatment of allodynia, hyperalgesia, spontaneous pain and phantom painNSGENE AS·Filed 2014·Granted Apr 19, 2016·0 cites·16 claims
- 1361US2008227703A1Novel Neurotrophic FactorsJOHANSEN TEIT E·Filed 2007·Application pending·0 cites
- 1455US2004230043A1Novel neurotrophic factorsFiled 2004·Application pending·0 cites
- 1555US2013109624A1Novel neurotrophic factorsSAH DINAH W Y·Filed 2012·Application pending·0 cites
- 1654US10034918B2Therapeutic use of a growth factor, METRNLHOBA THERAPEUTICS APS·Filed 2017·Granted Jul 31, 2018·0 cites·20 claims
- 1754US2012252726A1Novel neurotrophic factorsJOHANSEN TEIT E·Filed 2011·Application pending·0 cites
- 1853US9675669B2Therapeutic use of a growth factor, METRNLNSGENE AS·Filed 2015·Granted Jun 13, 2017·0 cites·12 claims
- 1947US9861682B2Treatment of hyperalgesia, spontaneous pain, and phantom painHOBA THERAPEUTICS APS·Filed 2016·Granted Jan 9, 2018·0 cites·14 claims
- 2047US9474786B2Treatment of allodyniaJORGENSEN JESPER ROLAND·Filed 2012·Granted Oct 25, 2016·0 cites·19 claims
- 2144US2009136552A1Growth factors nsg28, nsg30, and nsg32GRONBORG METTE·Filed 2005·Application pending·0 cites
- 2239US9845344B2Therapeutic use of a growth factor, NsG33GRØNBORG METTE·Filed 2005·Granted Dec 19, 2017·0 cites·7 claims
- 2339US2012184492A1Therapeutic use of a growth factor, nsg33GROENBORG METTE·Filed 2011·Application pending·0 cites
- 2439US2004259779A1Novel neurotrophic factorsFiled 2002·Application pending·0 cites
- 2539US2002055467A1Novel neurotrophic factorsFiled 2001·Application pending·0 cites
- 2636US2009087474A1Therapeutic use of growth factors,nsg29 and nsg31PETERSEN THOMAS N·Filed 2006·Application pending·0 cites
- 2733US2012021039A1Expression of neuropeptides in mammalian cellsKUSK PHILIP·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →